Suppr超能文献

男性尿失禁的干细胞治疗

Stem Cell Therapy for Male Urinary Incontinence.

作者信息

Giberti C, Gallo F, Schenone M, Cortese P, Ninotta G

机构信息

Department of Surgery, Division of Urology, San Paolo Hospital, Savona, Italy.

出版信息

Urol Int. 2013;90(3):249-52. doi: 10.1159/000342415.

Abstract

INTRODUCTION

Among the medical and surgical options which have been proposed in the last years for the management of male stress urinary incontinence (SUI), stem cell therapy represents a new frontier treatment. The aim of this paper is to update the current status of stem cell therapy in animal and human studies for the management of iatrogenic male SUI.

MATERIAL AND METHODS

A PubMed review of the literature on stem cell therapy for the treatment of male SUI was performed.

RESULTS

Regarding animal studies, bone marrow-, muscle- and adipose-derived stem cells have been widely studied, showing regeneration of the urethral sphincter and recovery of the damaged pelvic nerves. With regard to human studies, only four papers are available in the literature using muscle- and adipose-derived stem cells which reported a significant improvement in sphincteric function and incontinence with no severe side effects.

CONCLUSIONS

In spite of these promising results, further studies are needed with longer follow-ups and larger numbers of patients in order to clarify the potential role of stem cell therapy for the treatment of male SUI.

摘要

引言

在过去几年中提出的用于治疗男性压力性尿失禁(SUI)的医学和外科治疗方法中,干细胞疗法是一种新的前沿治疗方法。本文旨在更新干细胞疗法在动物和人体研究中治疗医源性男性SUI的现状。

材料与方法

对PubMed上关于干细胞疗法治疗男性SUI的文献进行综述。

结果

关于动物研究,骨髓、肌肉和脂肪来源的干细胞已得到广泛研究,显示出尿道括约肌的再生和受损盆腔神经的恢复。关于人体研究,文献中仅有四篇使用肌肉和脂肪来源干细胞的论文,报告显示括约肌功能和尿失禁有显著改善,且无严重副作用。

结论

尽管取得了这些令人鼓舞的结果,但仍需要进行更长时间随访和更多患者参与的进一步研究,以阐明干细胞疗法在治疗男性SUI中的潜在作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验